Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Joint Metastasis Research Society-AACR Conference on Metastasis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 24, 389-399, April 1, 1964]
© 1964 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldman, R. D.
Right arrow Articles by Hall, T. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldman, R. D.
Right arrow Articles by Hall, T. C.

Lactic Dehydrogenase in Human Neoplastic Tissues*

Robert D. Goldman{dagger}, Nathan O. Kaplan and Thomas C. Hall

( Graduate Department of Biochemistry, Brandeis University, Waltham, Massachusetts, and Children's Cancer Research Foundation, Boston, Massachusetts)

A definite and consistent shift in the pattern of molecular forms of lactic dehydrogenase (LDH) has been found in a large series of malignant human neoplasms as compared with benign tumors and normal controls. This has been associated in most cases with an absolute increase in the muscle-type LDH (migrating negatively on electrophoresis). No correlation was found between the degree of these changes and the histologic grading of the tumors. Suggestive but not conclusive evidence was found for an increase in total LDH activity in malignant tumors. In contrast, metastatic nodules were shown to have lower enzyme activity levels and different LDH compositions when compared with their associated primary tumors. The benign tumors were essentially indistinguishable from their normal tissue of origin.

The significance of these findings in relation to the known characteristic increase of glycolytic activity in malignant neoplasms is discussed. Consideration is also given to the possible implications of these results for carcinogenesis and cancer chemotherapy.

* Publication No. 258 from the Graduate Department of Biochemistry, Brandeis University, Waltham, Massachusetts. Supported in part by grants from the National Institutes of Health (Contract SA-43-ph-2440) and the American Cancer Society (P77-E, The Thomas S. Miller Memorial Grant for Cancer Research).

{dagger} Public Health Service Fellow (Grant No. GSP-16,561). Present address: Division of Experimental Medicine, University of Oregon Medical School, Portland, Oregon.

Received 8/22/63.


This article has been cited by other articles:


Home page
ScienceHome page
S. Lindy and M. Rajasalmi
Lactate Dehydrogenase Isozymes of Chick Embryo: Response to Variations of Ambient Oxygen Tension
Science, September 16, 1966; 153(3742): 1401 - 1403.
[Abstract] [PDF]


Home page
ScienceHome page
E. S. Vesell
Lactate Dehydrogenase Isozymes: Substrate Inhibition in Various Human Tissues
Science, December 17, 1965; 150(3703): 1590 - 1593.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1964 by the American Association for Cancer Research.